Abstract
INTRODUCTIONNew nanoparticulate blend compositions based on poly(D,L lactic-co-glycolic acid) (PLGA) and poly(ethylene oxide) (PEO) derivatives have been designed as transmucosal gene carriers. These nanosystems benefit from the inherent biodegradability and low toxicity of their components and the mild conditions required for their preparation. In addition, specific advantages of these nanoparticles for in vivo gene delivery are (1) their adequate DNA loading capacity, (2) their ability to control the release of the encapsulated DNA for extended periods of time while preserving its delicate conformational structure as well as its biological activity, and (3) their capacity to overcome the nasal mucosa barrier and transport the associated model DNA vaccine, leading to a significant systemic immune response against the encoded protein. This protocol describes the preparation and characterization of DNA-loaded nanoparticles composed of poly(lactic acid) (PLA) and PEO and the use of these particles as transmucosal gene delivery carriers.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
